Clinical Trial

Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes

Name: Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes — clinical trial record (NCT06838286)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TRIO

Recruiting

View on ClinicalTrials.gov →

Summary

A multicenter, prospective, non-interventional observation study to evaluate the safety and effectiveness of OAD triple therapy in Korean Type 2 diabetic mellitus patients.

Trial Details

NCT Number	NCT06838286
Lead Sponsor	Chong Kun Dang Pharmaceutical
Conditions	Diabetes Mellitus, Type 2
Enrollment	10,000 participants
Start Date	2024-03-16
Primary Completion	2026-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-02-20